Nicole L. Pershing
No Rating Available
(Learn About Our Rating System)

Nicole L. Pershing, MD, PHD

Languages spoken: English

  • Dr. Pershing completed her medical degree at Duke University School of Medicine. She then completed her residency in Pediatrics and fellowship in Pediatric Infectious Disease at the University of Utah and Primary Children’s Hospital. She is currently an Adjunct Instructor in the Division of Pediatric Infectious Disease at University of Utah.


    Dr. Pershing’s clinical interests include treatment and prevention of general infectious diseases, with a special interest in serious bacterial infections. Dr. Pershing’s research interests include investigation of bacterial, viral, and patient factors that contribute to severe bacterial infections.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Infectious Diseases)

  • Dr. Pershing completed her medical degree at Duke University School of Medicine. She then completed her residency in Pediatrics and fellowship in Pediatric Infectious Disease at the University of Utah and Primary Children’s Hospital. She is currently an Adjunct Instructor in the Division of Pediatric Infectious Disease at University of Utah.


    Dr. Pershing’s clinical interests include treatment and prevention of general infectious diseases, with a special interest in serious bacterial infections. Dr. Pershing’s research interests include investigation of bacterial, viral, and patient factors that contribute to severe bacterial infections.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Infectious Diseases
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Infectious Diseases)

    Selected Publications

    Journal Article

    1. Le Roux, Pershing NLK, Kaltenbrun E, Newman NJ, Everitt JI, Baldelli E, Pierobon M, Petricoin EF, Counter CM (2022). Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis. Elife, 11. (Read full article)
    2. Gladstone RA, Lo SW, Goater R, Yeats C, Taylor B, Hadfield J, Lees JA, Croucher NJ, van Tonder AJ, Bentley LJ, Quah FX, Blaschke AJ, Pershing NL, Byington CL, Balaji V, Hryniewicz W, Sigauque B, Ravikumar KL, Almeida SCG, Ochoa TJ, Ho PL, du Plessis M, Ndlangisa KM, Cornick JE, Kwambana-Adams B, Benisty R, Nzenze SA, Madhi SA, Hawkins PA, Pollard AJ, Everett DB, Antonio M, Dagan R, Klugman KP, von Gottberg A, Metcalf BJ, Li Y, Beall BW, McGee L, Breiman RF, Aanensen DM, Bentley SD, The Global Pneumococcal Sequencing Consortium (2020). Visualizing variation within Global Pneumococcal Sequence Clusters (GPSCs) and country population snapshots to contextualize pneumococcal isolates. Microb Genom, 6(5). (Read full article)
    3. Pershing NL, Yang CFJ, Xu M, Counter CM (2015). Treatment with the nitric oxide synthase inhibitor L-NAME provides a survival advantage in a mouse model of Kras mutation-positive, non-small cell lung cancer. Oncotarget, 7(27), 42385-42392. (Read full article)
    4. Pershing NL, Lampson BL, Belsky JA, Kaltenbrun E, MacAlpine DM, Counter CM (2014). Rare codons capacitate Kras-driven de novo tumorigenesis. J Clin Invest, 125(1), 222-33. (Read full article)
    5. Lampson BL, Pershing NL, Prinz JA, Lacsina JR, Marzluff WF, Nicchitta CV, MacAlpine DM, Counter CM (2012). Rare codons regulate KRas oncogenesis. Curr Biol, 23(1), 70-5. (Read full article)
    6. Kashatus DF, Lim KH, Brady DC, Pershing NL, Cox AD, Counter CM (2011). RALA and RALBP1 regulate mitochondrial fission at mitosis. Nat Cell Biol, 13(9), 1108-15. (Read full article)